Skip to main content
. 2016 Jul 22;11(7):e0159012. doi: 10.1371/journal.pone.0159012

Table 1. Comparison of demographics and comorbidity between ACOS and non-ACOS cohorts.

ACOS
No (N = 42966) Yes (N = 10751)
n % n % p-value
Sex 0.97
Women 19161 44.6 4792 44.6
Men 23805 55.4 5959 55.4
Age, year 0.99
20–35 1560 3.63 390 3.63
35–65 17740 41.3 4435 41.3
≥65 23666 55.1 5926 55.1
Mean (SD) # 64.2 (14.4) 64.6 (14.4) 0.26
Comorbidity
AR 4852 11.3 3244 30.2 < .0001
AD 1079 2.51 441 4.10 < .0001
AC 9399 21.9 3080 28.6 < .0001
Alcohol-related illness 592 1.38 329 3.06 < .0001
Diabetes 9568 22.3 2982 27.7 < .0001
Hypertension 21166 49.3 6836 63.6 < .0001
Hyperlipidemia 11603 27.0 3698 34.4 < .0001
Pneumonia 8397 19.5 4161 38.7 < .0001
IHD 12042 28.0 4742 44.1 < .0001
Stroke 8724 20.3 3072 28.6 < .0001
PPF 80 0.19 57 0.53 < .0001
Cancer 1476 3.44 380 3.53 0.61
HIV infection 8 0.02 2 0.02 0.99

Chi-square test

# Student’s t-test.

ACOS, asthma–COPD overlap syndrome; AR, allergic rhinitis; AD, atopic dermatitis; AC, allergic conjunctivitis; IHD, ischemic heart disease; PPF, postinflammatory pulmonary fibrosis.